# Sofosbuvir/Velpatasvir in Postpartum Women With Opioid Use Disorder and Chronic Hepatitis C Infection

> **NCT03057847** · PHASE4 · COMPLETED · sponsor: **Elizabeth Krans, MD** · enrollment: 32 (actual)

## Conditions studied

- Hepatitis C, Chronic
- Opioid-use Disorder

## Interventions

- **DRUG:** Sofosbuvir/Velpatasvir

## Key facts

- **NCT ID:** NCT03057847
- **Lead sponsor:** Elizabeth Krans, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-30
- **Primary completion:** 2022-02-24
- **Final completion:** 2022-02-24
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2023-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03057847

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03057847, "Sofosbuvir/Velpatasvir in Postpartum Women With Opioid Use Disorder and Chronic Hepatitis C Infection". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03057847. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*